Cambridge gene therapy firm Dimension Therapeutics to be acquired
August 25, 2017 at 08:25 AM EDT
The proposed acquisition by Maryland-based Regenxbio values the company at just $86 million, a fraction of Dimension's value a year ago.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|